X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (79) 79
Patent (22) 22
Newspaper Article (11) 11
Book Chapter (5) 5
Publication (3) 3
Book / eBook (2) 2
Conference Proceeding (2) 2
Book Review (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (29) 29
human necessities (22) 22
hygiene (22) 22
medical or veterinary science (22) 22
preparations for medical, dental, or toilet purposes (22) 22
female (18) 18
specific therapeutic activity of chemical compounds ormedicinal preparations (18) 18
male (14) 14
index medicus (13) 13
adult (8) 8
middle aged (8) 8
breast cancer (7) 7
breast neoplasms - genetics (6) 6
breast neoplasms - pathology (6) 6
dna-binding proteins - genetics (6) 6
hematology (6) 6
united kingdom (6) 6
aged (5) 5
medicine, general & internal (5) 5
public, environmental & occupational health (5) 5
science (5) 5
animals (4) 4
article (4) 4
cancer (4) 4
children (4) 4
drug resistance (4) 4
estrogen receptor alpha - metabolism (4) 4
mcf-7 cells (4) 4
molecular sequence data (4) 4
multidisciplinary sciences (4) 4
oncology (4) 4
population (4) 4
repressor proteins - genetics (4) 4
research (4) 4
research article (4) 4
risk factors (4) 4
type 2 diabetes (4) 4
actors (3) 3
analysis (3) 3
binding (3) 3
biochemistry & molecular biology (3) 3
breast neoplasms - drug therapy (3) 3
breast neoplasms - metabolism (3) 3
care and treatment (3) 3
cell line, tumor (3) 3
chemistry (3) 3
child (3) 3
cholesterol (3) 3
core binding factor alpha 2 subunit (3) 3
cytoskeleton (3) 3
diabetes (3) 3
further section (3) 3
gene expression (3) 3
gene-expression (3) 3
genetic aspects (3) 3
health (3) 3
health aspects (3) 3
health behavior (3) 3
internal medicine (3) 3
management (3) 3
medicine & public health (3) 3
metabolism (3) 3
metallurgy (3) 3
metastasis (3) 3
morphine (3) 3
organic chemistry (3) 3
patients (3) 3
peptides (3) 3
pioneer factors (3) 3
precursor cell lymphoblastic leukemia-lymphoma - genetics (3) 3
prevention (3) 3
prognosis (3) 3
proto-oncogene proteins - genetics (3) 3
proto-oncogene proteins c-ets (3) 3
resistance (3) 3
risk (3) 3
science & technology (3) 3
self-management (3) 3
transcription factors - genetics (3) 3
transplantation (3) 3
tumors (3) 3
abridged index medicus (2) 2
acute disease (2) 2
acute lymphoblastic-leukemia (2) 2
acute myeloid-leukemia (2) 2
adaptor proteins, signal transducing - genetics (2) 2
aged, 80 and over (2) 2
aging (2) 2
alleles (2) 2
antigens, neoplasm - genetics (2) 2
antineoplastic agents - metabolism (2) 2
antineoplastic agents, hormonal - pharmacology (2) 2
antineoplastic agents, hormonal - therapeutic use (2) 2
aromatase inhibitors - pharmacology (2) 2
aromatase inhibitors - therapeutic use (2) 2
asparaginase - metabolism (2) 2
author (2) 2
base sequence (2) 2
binding sites (2) 2
blood (2) 2
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (116) 116
French (7) 7
Spanish (2) 2
Bulgarian (1) 1
Czech (1) 1
Estonian (1) 1
German (1) 1
Icelandic (1) 1
Norwegian (1) 1
Portuguese (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Chest, ISSN 0012-3692, 10/2019, Volume 156, Issue 4, pp. A1516 - A1517
Journal Article
Chest, ISSN 0012-3692, 10/2019, Volume 156, Issue 4, pp. A183 - A183
Journal Article
Chest, ISSN 0012-3692, 10/2019, Volume 156, Issue 4, pp. A1516 - A1517
Journal Article
Nature Communications, ISSN 2041-1723, 11/2015, Volume 6, Issue 1, p. 10044
Journal Article
Nature communications, ISSN 2041-1723, 08/2019, Volume 10, Issue 1, pp. 3791 - 1
An amendment to this paper has been published and can be accessed via a link at the top of the paper. 
Keratins | Keratin | Cytoskeleton | Breast cancer | Invasiveness
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 05/2019, Volume 10, Issue 1, pp. 2115 - 15
Approximately 30% of ER alpha breast cancer patients relapse with metastatic disease following adjuvant endocrine therapies. The connection between acquisition... 
MIGRATION | CELLS | THERAPY | CHOLESTEROL | TAMOXIFEN | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | PROGRESSION | Up-Regulation | Prognosis | Keratins, Type II - metabolism | Aromatase Inhibitors - pharmacology | Epigenesis, Genetic | Humans | Gene Expression Regulation, Neoplastic | Neoplasm Recurrence, Local - drug therapy | Neoplasm Recurrence, Local - mortality | Protein Domains - genetics | Cell Movement - genetics | Neoplasm Recurrence, Local - pathology | MCF-7 Cells | Neoplasm Invasiveness - pathology | Antineoplastic Agents, Hormonal - therapeutic use | Estrogen Receptor alpha - metabolism | Female | Aromatase Inhibitors - therapeutic use | Breast - pathology | Sterol Regulatory Element Binding Protein 1 - metabolism | Cytoskeleton - pathology | Antineoplastic Agents, Hormonal - pharmacology | Cytoskeleton - genetics | Breast Neoplasms - drug therapy | Cell Movement - drug effects | Drug Resistance, Neoplasm - genetics | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Neoplasm Recurrence, Local - genetics | Enhancer Elements, Genetic - genetics | Neoplasm Invasiveness - genetics | Keratins, Type II - genetics | Immunohistochemistry | Invasiveness | Elasticity | Breast cancer | Stiffening | Drug resistance | Patients | Metastases | Keratin | Aromatase | Sterol regulatory element-binding protein | Epigenetics | Cytoskeleton | Tumors
Journal Article
Nature communications, ISSN 2041-1723, 08/2019, Volume 10, Issue 1, pp. 3505 - 1
An amendment to this paper has been published and can be accessed via a link at the top of the paper. 
Biosynthesis | Cholesterol
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2014, Volume 9, Issue 12, p. e115346
Background: Intratumoral heterogeneity may help drive resistance to targeted therapies in cancer. In breast cancer, the presence of nodal metastases is a key... 
OVEREXPRESSION | METASTASIS | MULTIDISCIPLINARY SCIENCES | DISEASE | GENE-EXPRESSION | CLINICAL-IMPLICATIONS | CARCINOMAS | CLONAL EVOLUTION | TP53 MUTATIONS | CHROMOSOMAL INSTABILITY | REVEALS | Antigens, Neoplasm - genetics | Humans | Repressor Proteins - genetics | Lymphatic Metastasis | Transcription Factors - genetics | DNA-Binding Proteins - genetics | Genetic Heterogeneity | Homeodomain Proteins - genetics | Tumor Suppressor Protein p53 - genetics | Poly-ADP-Ribose Binding Proteins | Breast Neoplasms - genetics | Breast Neoplasms - pathology | Adaptor Proteins, Signal Transducing - genetics | DNA Topoisomerases, Type II - genetics | Female | Polymorphism, Single Nucleotide | GTPase-Activating Proteins - genetics | Genome, Human | Cyclin B2 - genetics | Case studies | Economic indicators | Analysis | Genomics | Breast cancer | Genomes | Genetic aspects | Nucleotide sequencing | Tumor proteins | Health aspects | DNA sequencing | Cancer | Transcription | p53 Protein | Insertion | Metastasis | Cancer therapies | Blood | Lymph nodes | Metastases | Gene sequencing | Heterogeneity | Alterations | Peripheral blood | DNA methylation | Deoxyribonucleic acid--DNA | Lymphatic system | Nucleotide sequence | Cell division | Gene expression | Medicine | Studies | Medical prognosis | Breast | Cytoskeleton | Protein expression | Mutation | Cell size | Tumors | Lymph | Deoxyribonucleic acid | DNA
Journal Article
1995, Professional ethics., ISBN 0415101093, x, 200
It has always been recognised that the practice of social work raises ethical questions and dilemmas. Recently, however, traditional ways of addressing ethical... 
Social workers | Moral and ethical aspects | Social service | Professional ethics | Philosophy | Medical Ethics | Ethics Philosophy | Moral and thical aspects
Book
Biochemical Pharmacology, ISSN 0006-2952, 01/2013, Volume 85, Issue 2, pp. 186 - 196
Triple-negative breast cancer is characterized by aggressive tumours whose cells lack oestrogen and progesterone receptors and do not over-express HER2. It... 
TOP2A | Collateral sensitivity | MGMT | Triple negative breast cancer | Tumor Suppressor Protein p53 - antagonists & inhibitors | Humans | Neoplasm Proteins - antagonists & inhibitors | G1 Phase - drug effects | Neoplasm Proteins - metabolism | Promoter Regions, Genetic - drug effects | Tumor Suppressor Protein p53 - genetics | Breast Neoplasms - metabolism | Antineoplastic Agents - metabolism | DNA-Binding Proteins - metabolism | Poly-ADP-Ribose Binding Proteins | Cyclin-Dependent Kinase Inhibitor p21 - genetics | O-Methylguanine-DNA Methyltransferase - antagonists & inhibitors | Biological Transport | Antineoplastic Agents - adverse effects | Antigens, Neoplasm - metabolism | Cyclin-Dependent Kinase Inhibitor p21 - metabolism | Inhibitory Concentration 50 | Female | Antineoplastic Agents - pharmacology | Doxorubicin - metabolism | Gene Expression Regulation, Neoplastic - drug effects | Neoplasm Proteins - genetics | Recombinant Proteins - metabolism | Antigens, Neoplasm - genetics | DNA Topoisomerases, Type II - metabolism | Recombinant Proteins - antagonists & inhibitors | DNA-Binding Proteins - antagonists & inhibitors | O-Methylguanine-DNA Methyltransferase - metabolism | Tumor Suppressor Protein p53 - metabolism | Recombinant Proteins - genetics | Topoisomerase II Inhibitors - pharmacology | Carmustine - pharmacology | DNA-Binding Proteins - genetics | Breast Neoplasms - drug therapy | O-Methylguanine-DNA Methyltransferase - genetics | Cyclin-Dependent Kinase Inhibitor p21 - agonists | Cell Line, Tumor | DNA Topoisomerases, Type II - genetics | Cell Proliferation - drug effects | DNA Methylation - drug effects | Doxorubicin - adverse effects | Doxorubicin - pharmacology | Drug Resistance, Neoplasm - drug effects
Journal Article